Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026

Envista Holdings (NVST)

NYSE Health Care Health Care Supplies S&P MidCap 400
$25.17
+0.21 (+0.84%)
Close of Nov 06, 2026 · end-of-day data
Source: Envista Holdings's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 05, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue$2.81B$2.84B$2.28B$1.93B$2.51B$2.57B$2.57B$2.51B$2.72B
Cost of revenue$1.19B$1.24B$935.60M$874.30M$1.08B$1.09B$1.13B$1.14B$1.23B
Gross profit$1.62B$1.60B$1.35B$1.05B$1.43B$1.47B$1.44B$1.37B$1.49B
Research & development$172.40M$172.00M$133.10M$86.70M$100.50M$100.10M$93.80M$99.10M$114.00M
Selling, general & admin$1.06B$1.13B$980.40M$924.60M$1.02B$1.06B$1.06B$1.16B$1.16B
Operating income$386.60M$298.40M$235.70M$43.50M$306.20M$319.20M$31.50M-$1.04B$216.10M
Interest expense$0$0$3.50M$62.50M$54.10M$38.40M$63.40M——
Pre-tax income$386.70M$301.10M$233.70M-$20.00M$254.50M$283.90M-$54.90M-$1.08B$177.20M
Income tax$85.60M$70.40M$49.60M-$62.50M-$9.00M$45.90M$45.30M$33.90M$130.20M
Net income$301.10M$230.70M$217.60M$33.30M$340.50M$243.10M-$100.20M-$1.12B$47.00M
EBITDA$508.00M$428.40M$356.10M$165.20M$424.00M$457.00M$167.10M-$915.10M$332.10M
EPS (basic)$2.35$1.80$1.60$0.21$2.11$1.49$-0.60$-6.50$0.28
EPS (diluted)$2.35$1.80$1.60$0.20$1.92$1.37$-0.60$-6.50$0.28
Diluted shares127.90M127.90M136.40M164.10M177.60M177.60M166.90M172.20M169.20M
Gross margin57.7%56.3%59.1%54.7%56.9%57.4%56.1%54.7%54.7%
Operating margin13.8%10.5%10.3%2.3%12.2%12.4%1.2%-41.4%7.9%
Net margin10.7%8.1%9.5%1.7%13.6%9.5%-3.9%-44.6%1.7%

Balance sheet

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash & equivalents$0$0$211.20M$888.90M$1.07B$606.90M$940.00M$1.07B$1.21B
Receivables—$459.80M$443.60M$301.70M$331.90M$393.50M$407.50M$363.00M$429.60M
Inventory—$278.70M$277.90M$216.00M$263.80M$300.80M$258.80M$241.00M$288.10M
Total current assets—$786.80M$1.00B$1.59B$1.84B$1.42B$1.74B$1.79B$2.03B
Goodwill$3.37B$3.33B$3.31B$3.21B$3.13B$3.50B$3.29B$2.26B$2.36B
Total assets$5.99B$5.84B$6.16B$6.88B$6.57B$6.59B$6.61B$5.35B$5.68B
Total current liabilities—$641.00M$709.20M$1.68B$1.21B$1.24B$780.80M$878.70M$852.60M
Short-term debt—$0$3.90M$886.80M$432.40M$510.00M$115.30M$116.00M$0
Long-term debt—$0$1.32B$907.70M$883.40M$870.70M$1.40B$1.28B$1.45B
Total debt—$0$1.32B$1.79B$1.32B$1.38B$1.51B$1.39B$1.45B
Total liabilities—$1.02B$2.62B$3.16B$2.52B$2.38B$2.43B$2.42B$2.57B
Shareholders' equity—$4.82B$3.54B$3.72B$4.06B$4.21B$4.17B$2.93B$3.11B

Cash flow

fiscal years · USD
Fiscal yearFY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow$359.10M$400.10M$397.50M$283.90M$361.60M$182.70M$275.70M$336.50M$275.70M
Capital expenditures$48.90M$72.20M$77.80M$47.70M$54.70M$75.70M$58.20M$33.80M$45.30M
Free cash flow$310.20M$327.90M$319.70M$236.20M$306.90M$107.00M$217.50M$302.70M$230.40M
Investing cash flow-$54.90M-$75.50M-$78.40M-$69.10M$262.70M-$657.30M-$62.40M-$54.60M-$51.10M
Financing cash flow-$304.20M-$324.60M-$107.70M$492.50M-$465.60M$12.50M$118.90M-$103.70M-$170.90M
Stock-based compensation$12.30M$13.30M$18.40M$22.60M$28.20M$30.50M$30.70M$35.30M$37.60M
Depreciation & amortization$121.40M$130.00M$120.40M$121.70M$117.80M$137.80M$135.60M$123.10M$116.00M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.